Abbott Labs (ABT): A Rich Pipeline in Pharma
“Because major U.S. pharmaceutical companies face patent expirations on blockbuster drugs, consensus earnings expectations for the group are modest,” says Richard Moroney . The editor of Dow Theory Forecasts explains, “One exception is Abbott
Moreover Technologies – Search results for… drugs – 30 of 727 returned
Leave a Reply
You must be logged in to post a comment.
